Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
McKesson
AstraZeneca
Harvard Business School

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Acetamide


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Acetamide?

Acetamide is an investigational drug.

There have been 13 clinical trials for Acetamide. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2016.

The most common disease conditions in clinical trials are Rectal Neoplasms, Substance-Related Disorders, and Liver Failure, Acute. The leading clinical trial sponsors are California Pacific Medical Center Research Institute, City of Hope Medical Center, and Virginia Clinical Research, Inc.

There are three US patents protecting this investigational drug and thirty-three international patents.

Recent Clinical Trials for Acetamide
TitleSponsorPhase
Modafinil's Effects on Cognition in Remitted MDDOntario Ministry of Health and Long Term CarePhase 3
Modafinil's Effects on Cognition in Remitted MDDThe Canadian Biomarker Integration Network in DepressionPhase 3
Modafinil's Effects on Cognition in Remitted MDDSt. Michael's Hospital, TorontoPhase 3

See all Acetamide clinical trials

Clinical Trial Summary for Acetamide

Top disease conditions for Acetamide
Top clinical trial sponsors for Acetamide

See all Acetamide clinical trials

US Patents for Acetamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Acetamide   Start Trial Method for processing silver halide color photographic material for prints Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Acetamide   Start Trial 1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders Marion Laboratories, Inc. (Kansas City, MO)   Start Trial
Acetamide   Start Trial 7-substituted bicyclic pyrazolidinones Eli Lilly and Company (Indianapolis, IN)   Start Trial
Acetamide   Start Trial Novel esters of phenylalkanoic acid Ono Pharmaceutical Co., Ltd. (Osaka, JP)   Start Trial
Acetamide   Start Trial Substituted propane-phosphinic acid compounds Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Acetamide

Drugname Country Document Number Estimated Expiration Related US Patent
Acetamide Germany 3786681 2006-01-27   Start Trial
Acetamide European Patent Office 0231861 2006-01-27   Start Trial
Acetamide Japan S62275256 2006-01-27   Start Trial
Acetamide Austria 127117 2008-04-28   Start Trial
Acetamide Australia 634604 2008-04-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Colorcon
Medtronic
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.